Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

Delayed Quote. Delayed  - 07/29 10:00:43 pm
44.75 USD   +0.67%
07/29DJABBVIE : Results Boosted by Humira, Pipeline Growth
07/29DJABBVIE : Results Boosted by Humira, Pipeline Growth
07/28 THURSDAY 7/28 I : Abt, ancx
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Abbott Laboratories : Abbott and AbbVie Announce Investor Calls

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/14/2013 | 04:10pm CEST

Abbott Park, Illinois and North Chicago - Abbott (NYSE: ABT) will announce its fourth-quarter and full-year 2012 financial results on Wednesday, Jan. 23, 2013, before the market opens.

Abbott's quarterly and annual results will include contributions from the company's former research-based pharmaceutical business, which became AbbVie on Jan. 1, 2013. While these results will be captured in a single press release, both companies will host separate conference calls to discuss their respective business results and 2013 outlooks.

Abbott will host a live webcast of the earnings conference call at 8 a.m. Central time (9 a.m. Eastern) on Jan. 23, 2013. It will be accessible through Abbott's Investor Relations website at www.abbottinvestor.com. An archived edition of the call will be available after 11 a.m. Central time.

On Wednesday, Jan. 30, 2013, AbbVie will host a live webcast at 8 a.m. Central time (9 a.m. Eastern) accessible through AbbVie's Investor Relations website at www.abbvieinvestor.com. An archived edition of the call will be available after 11 a.m. Central time.

About Abbott

Abbott (NYSE: ABT) is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. With a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals, Abbott serves people in more than 150 countries and employs approximately 70,000 people.

About AbbVie

AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. With its 125-year history, the company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. In 2013, AbbVie employs approximately 21,000 people worldwide and markets medicines in more than 170 countries.www.abbvie.com. Follow @abbvie on Twitter or view careers on our Facebook or LinkedIn page.

Abbott Contacts:
Media:
Scott Stoffel

(847) 936-9502
Financial:
Brian Yoor

(847) 937-6343
AbbVie Contacts:
Media:
Adelle Infante

(847) 938-8745
Financial:
Larry Peepo

(847) 935-6722
distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ABBOTT LABORATORIES
07/29DJABBVIE : Results Boosted by Humira, Pipeline Growth
07/29DJABBVIE : Results Boosted by Humira, Pipeline Growth
07/28 ABBOTT LABORATORIES : Trademark Application for "CELL-DYN RUBY" Filed by Abbott ..
07/28 ABBOTT LABORATORIES : Federal Contracts Awarded by Federal Agencies in Iowa (Jul..
07/28 ABBOTT LABORATORIES : Trademark Application for "GERMIGUARD" Filed by Abbott Lab..
07/28 THURSDAY 7/28 INSIDER BUYING REPORT : Abt, ancx
07/28 DGAP-DD : Abbott Laboratories english
07/28 ABBOTT LABORATORIES : $30,000 Federal Contract Awarded to Abbott Laboratories
07/28DJALERE : Faces Criminal Probe Over Billing -- WSJ
07/28 ABBOTT LABORATORIES : has more reason to walk away from Alere deal
More news
Sector news : Pharmaceuticals - NEC
01:14a BAYER : says will halt future U.S. sales of insecticide
07/29DJTech Stocks Up On Google Earnings - Tech Roundup
07/29DJMERCK : Revenue Rises on Cancer, Hepatitis Treatments -- Update
07/29DJABBVIE : Results Boosted by Humira, Pipeline Growth
07/29DJMerck Revenue Rises on Cancer, Hepatitis Treatments
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
07/29 3 Free Options
07/29 Oracle's Larry Ellison Wants To Own It All - Starting With NetSuite (Podcast)
07/28 Alere Stock Goes Nuts, Abbott Likely Still Picking Up The Tab
07/28 Larry Ellison Conquers The World, Starting With NetSuite
07/28 INSIDERINSIGHTS.COM DAILY ROUND UP 7 : Blackrock Debt Strategies Fund, Bank Of C..
Advertisement
Financials ($)
Sales 2016 20 942 M
EBIT 2016 4 080 M
Net income 2016 2 323 M
Debt 2016 2 655 M
Yield 2016 2,34%
P/E ratio 2016 24,81
P/E ratio 2017 19,35
EV / Sales 2016 3,25x
EV / Sales 2017 3,09x
Capitalization 65 304 M
More Financials
Chart ABBOTT LABORATORIES
Duration : Period :
Abbott Laboratories Technical Analysis Chart | ABT | US0028241000 | 4-Traders
Full-screen chart
Technical analysis trends ABBOTT LABORATORIES
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 47,6 $
Spread / Average Target 7,2%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Miles D. White Chairman & Chief Executive Officer
Brian B. Yoor Chief Financial Officer & Senior VP-Finance
Roxanne Schuh Austin Independent Director
Jim Farrell Independent Director
Samuel C. Scott Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ABBOTT LABORATORIES-0.36%65 304
JOHNSON & JOHNSON21.91%342 345
PFIZER INC.14.28%222 398
ROCHE HOLDING LTD.-9.99%215 597
NOVARTIS AG-5.30%214 061
MERCK & CO., INC.11.06%161 736
More Results